Market Research Report
North America Opioids Drug Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||757038|
|Published||Content info||82 Pages
Delivery time: 1-2 business days
|North America Opioids Drug Market Forecast 2019-2027|
|Published: December 17, 2018||Content info: 82 Pages||
The North America opioids drug market is expected to grow at a CAGR of 2.29% throughout the forecast period of 2019-2027. This regional market has been valued $ XX million and is predicted to reach $XX million by 2027. Circumstances like the rising incidences of opioid abuse and addiction and stringent regulatory conditions for opioid drug sales in the healthcare sector are impeding the growth of the market in the region.
The countries of the U.S. and Canada are mainly considered for this particular market study. The United States contributes the largest shares for the market. The increasing cases of road accidents & surgeries are proliferating the market growth. The opioid drugs are prescribed for relieving the pain associated with injury caused due to severe accidents which occurs very frequently in the congested transport routes in developed nations like that of the United States, Canada, among others. Also, some of these cases can lead to unfortunate cases of extreme spinal cord injuries that can cause associated incurable pains. Here, mostly opioids meds are prescribed. Pharmaceutical companies are investing in the development of novel opioid drugs due to its growing demand in the novel therapeutics for pain management.
Sun Pharmaceutical Industries Limited (Sun Pharma), Indivior, Inc., Daiichi Sankyo, Inc., Acura Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Insys Therapeutics, Inc., Allergan PLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lannett Co. Inc., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Lupin Ltd. and Teva Pharmaceutical Industries Ltd. are some of the competing market players.